27. Introduction to molecular pathology Flashcards
Molecular techniques
Tissue based:
- protein-based
- immunohistochemistry
- detects protein using antibodies with a label directed against the protein - nucleic acid based
- extract DNA/RNA from tissue
- identify area of interest
- use complementary nucleic acid probes for translocation
- use sequencing for mutation
Technique for DNA or RNA
FISH (Flourescence In Situ Hybridisation)
-fluorescence probe
CISH (Chromogenic In Situ Hybridisation)
-chromogen probe
When is FISH/CISH used
good for translocations
- Bcl2 in lymphoma
- Her2 in breast carcinoma
- c-Myc in Burkitt’s lymphoma
Genetic changes in follicular lymphoma
-caused by t(14; 18) which activates an anti-apoptotic gene Bcl2
What is sequencing of DNA/RNA for
process of determining the identity and order of nucleotides in a segment of DNA/RNA
How is mutation detected
- PCR
2. Sequencing
Gene abnormality is detected by
- PCR
- sequencing (automated next generation sequencing)
- FISH
- CISH
Protein expression is detected by
immunohistochemistry
Alteration of which 4 types of gene will lead to cancer
- oncogenes
- tumour suppressor gene
- mismatch repair gene
- anti-apoptotic gene
What are receptor tyrosine kinase
high affinity cell surface receptors for many polypeptide growth factors, cytokines and hormones
What are tyrosine kinase
kinase enzymes that specifically phosphorylate tyrosine on amino acid
Effects of phosphorylation of tyrosine on amino acid
activation of cell signalling and may cause a constant “on” activation
How does oncogene works
- dominant
- activation by mutation, translocation, amplification
- mutation detected by:
a) protein level - immunohistochemistry
b) mRNA - RT-PCR
c) DNA - PCR and sequencing
How does tumour suppressor gene works
- recessive
- inactivation due to either loss of both alleles or methylation
- double hit required
- found in all types of neoplasia
- most common
Example of activated proto-oncogenes
- c-ras
- 50% of cancers - c-Myc
- Burkitt’s lymphoma - c-abl
- chronic granulocytic leukemia - c-ret
- thyroid carcinoma